InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Sklawer Andrew D, 首席执行官. Officer active across 3 companies, notably Brickell Biotech, Inc.. Aggregated, 2 reports have been logged. Split: 1 buy · 0 sell. Total volume traded: €10k. History available since 17 May 2021. The latest transaction was disclosed on 17 May 2021 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Sklawer Andrew D
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
55,000 股Common StockSEC:0001628280-23-033916:0
15,375 股@ US$0.80100.0% 占其流量Common StockSEC:0001062993-21-004868:0
标准退出：2021年8月15日 (T+90)
2 条申报中的 2 条
About Sklawer Andrew D
Sklawer Andrew D is the COO and Secretary at Brickell Biotech, Inc. He oversees the company's operations and ensures compliance of processes. His role is essential for the effective management of the organization.
